secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001493152-25-002398
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed stockholders approve 4x increase in authorized shares to 250M and Series C Preferred issuance
--------------------------------------------------------------------------------

- Stockholders approved amending the certificate of incorporation to increase authorized common shares from 50M to 250M, effective Jan 15, 2025.
- Stockholders also approved the issuance of common stock upon conversion of Series C Convertible Preferred shares.
- Series C Preferred will be issued under a Debt Exchange Agreement and a Securities Purchase Agreement, both dated November 2024.
- Company expects to consummate the Series C Preferred issuance and debt exchange by January 31, 2025.
- Vote tallies: For amendment 5.23M vs 0.72M against; for issuance 5.48M vs 0.46M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225002398/0001493152-25-002398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315225002398/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-002398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer